Firm closes deal with Oxford Finance

Share this content:


Oxford Finance has closed a senior credit facility with Diversis Capital, a private equity firm.

Oxford was the sole lender and administrative agent for this transaction. Funds were used for the acquisition of Caligor Rx, which provides comparator drugs for clinical trials. It also manages the regulatory and logistics of sourcing investigational drugs.

Diversis Capital was founded in 2016.